COST-EFFECTIVENESS OF QUADRIVALENT INFLUENZA VACCINE HIGH DOSE VERSUS ADJUVANTED STANDARD DOSE TRIVALENT INFLUENZA VACCINE IN ENGLAND

被引：0
|
作者：
Gibbons, I [1 ]
Davidson, C. [1 ]
Clark-Wright, J. [1 ]
Miller, C. [2 ]
Carroll, S. [1 ]
Costa, M. [3 ]
Bricout, H. [4 ]
Alvarez, F. P. [4 ]
机构：
[1] Sanofi Pasteur, Reading, Rdg, England
[2] Sanofi Pasteur, Church Crookham, Ham, England
[3] Syneos Hlth, London, Lon, England
[4] Sanofi Pasteur, Lyon, France
来源：
VALUE IN HEALTH | 2020年 / 23卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PIN60
引用
收藏
页码：S554 / S554
页数：1
相关论文
共 50 条
  • [21] Cost-Effectiveness of the Use of Adjuvanted Quadrivalent Seasonal Influenza Vaccine in Older Adults in Ireland
    Nguyen, Van Hung
    Ashraf, Mansoor
    Mould-Quevedo, Joaquin F. F.
    [J]. VACCINES, 2023, 11 (05)
  • [22] Comparative effectiveness of high dose versus adjuvanted influenza vaccine: A retrospective cohort study
    van Aalst, Robertus
    Gravenstein, Stefan
    Mor, Vincent
    Mahmud, Salaheddin M.
    Wilschut, Jan
    Postma, Maarten
    Chit, Ayman
    [J]. VACCINE, 2020, 38 (02) : 372 - 379
  • [23] Cost-Effectiveness of Vaccination of Older Adults with an MF59®-Adjuvanted Quadrivalent Influenza Vaccine Compared to Standard-Dose and High-Dose Vaccines in Denmark, Norway, and Sweden
    Jacob, Jorge
    Biering-Sorensen, Tor
    Holger Ehlers, Lars
    Edwards, Christina H.
    Mohn, Kristin Greve-Isdahl
    Nilsson, Anna
    Hjelmgren, Jonas
    Ma, Wenkang
    Sharma, Yuvraj
    Ciglia, Emanuele
    Mould-Quevedo, Joaquin
    [J]. VACCINES, 2023, 11 (04)
  • [24] Assessing optimal use of the standard dose adjuvanted trivalent seasonal influenza vaccine in the elderly
    Thorrington, Dominic
    van Leeuwen, Edwin
    Ramsay, Mary
    Pebody, Richard
    Baguelin, Marc
    [J]. VACCINE, 2019, 37 (15) : 2051 - 2056
  • [25] COST-EFFECTIVENESS ANALYSIS OF QUADRIVALENT INFLUENZA VACCINE IN SPAIN
    Garcia Rojas, A.
    Ortiz de Lejarazu, R. L.
    Reina, J.
    Callejo, D.
    Cuervo Uria, J.
    Morano Larragueta, R.
    [J]. VALUE IN HEALTH, 2015, 18 (07) : A588 - A588
  • [26] A SYSTEMATIC REVIEW OF THE COST-EFFECTIVENESS OF QUADRIVALENT INFLUENZA VACCINE
    van Maanen, B. M.
    Postma, M. J.
    de Boer, P. T.
    [J]. VALUE IN HEALTH, 2016, 19 (07) : A414 - A414
  • [27] Cost-effectiveness analysis of quadrivalent influenza vaccine in Spain
    Garcia, Amos
    Ortiz de Lejarazu, Raul
    Reina, Jordi
    Callejo, Daniel
    Cuervo, Jesus
    Morano Larragueta, Raul
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2016, 12 (09) : 2269 - 2277
  • [28] COST-EFFECTIVENESS ANALYSIS OF SWITCHING FROM A TRIVALENT TO A QUADRIVALENT INACTIVATED INFLUENZA VACCINE IN COLOMBIA
    Castro, R.
    Rueda, J. A.
    Drzewiecka, A.
    Gorecki, M.
    [J]. VALUE IN HEALTH, 2023, 26 (06) : S162 - S162
  • [29] Cost-Effectiveness Analysis of Switching from Trivalent to Quadrivalent Seasonal Influenza Vaccine in Argentina
    Uruena, Analia
    Micone, Paula
    Magneres, Cecilia
    Mould-Quevedo, Joaquin
    Giglio, Norberto
    [J]. VACCINES, 2021, 9 (04)
  • [30] Expected cost effectiveness of high-dose trivalent influenza vaccine in US seniors
    Chit, Ayman
    Roiz, Julie
    Briquet, Benjamin
    Greenberg, David P.
    [J]. VACCINE, 2015, 33 (05) : 734 - 741
12345